Showing results (1-10 of 96) with videos related to
Sort By:
Pageof 10
Fundamental & Clinical Pharmacology|March 10, 2009
Unmet needs in oral antiplatelet therapy with ADP receptor blocking agentsSteen HustedInternational Journal of Cardiology|March 14, 2009
Evidence-based prescribing and adherence to antiplatelet therapy--how much difference do they make to patients with atherothrombosis?Steen HustedPostgraduate Medicine|November 23, 2011
Evaluating the risk-benefit profile of the direct-acting P2Y(12) inhibitor ticagrelor in acute coronary syndromesSteen HustedTherapeutics and Clinical Risk Management|March 4, 2015
Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patientsSteen HustedAdvances in Cardiology|August 22, 2012
Antiplatelet therapy in acute coronary syndromes: ticagrelorSteen HustedDrugs & Aging|March 5, 2016
Safety of Antithrombotic Agents in Elderly Patients with Acute Coronary SyndromesBianca Rocca, Steen HustedAmerican Journal of Therapeutics|April 2, 2015
Case Study: Ticagrelor in PLATO and Prasugrel in TRITON-TIMI 38 and TRILOGY-ACS Trials in Patients With Acute Coronary SyndromesSteen Husted, Eric BoersmaCardiovascular Therapeutics|July 17, 2009
Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonistSteen Husted, J J J van GiezenJournal of the Neurological Sciences|September 1, 2004
Dipyridamole and headache--a pilot study of initial dose titrationArne Lindgren, Steen Husted, Gert Staaf, et al.Drug Safety|November 1, 2015
Reversal Strategies for NOACs: State of Development, Possible Clinical Applications and Future PerspectivesSteen Husted, Freek W A Verheugt, Willemijn J ComuthPageof 10